K. Warecka

484 total citations
30 papers, 328 citations indexed

About

K. Warecka is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, K. Warecka has authored 30 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in K. Warecka's work include Glycosylation and Glycoproteins Research (13 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and S100 Proteins and Annexins (5 papers). K. Warecka is often cited by papers focused on Glycosylation and Glycoproteins Research (13 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and S100 Proteins and Annexins (5 papers). K. Warecka collaborates with scholars based in Germany, France and United States. K. Warecka's co-authors include Heike Bauer, David W.M. Muller, Holger Jon Møller, H. Vogel, Eric G. Brunngraber, Reinhard Eggers, D. Claus, Martin Schürmann, B. Neund�rfer and Søren Rasmussen and has published in prestigious journals such as Neurology, Neuroscience and Journal of Neurochemistry.

In The Last Decade

K. Warecka

29 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Warecka Germany 11 214 47 43 41 39 30 328
Keith Del Villar United States 9 246 1.1× 56 1.2× 20 0.5× 27 0.7× 43 1.1× 12 369
Perry J. Hartfield Australia 10 299 1.4× 52 1.1× 59 1.4× 18 0.4× 40 1.0× 20 481
Kenji Yamamoto Japan 7 167 0.8× 187 4.0× 31 0.7× 30 0.7× 28 0.7× 8 398
Tessa Grabinski United States 11 347 1.6× 137 2.9× 29 0.7× 36 0.9× 66 1.7× 15 551
V. T. Solovyan Ukraine 10 255 1.2× 37 0.8× 21 0.5× 24 0.6× 63 1.6× 24 368
Jacqueline Tiong Canada 10 194 0.9× 60 1.3× 199 4.6× 30 0.7× 33 0.8× 10 473
Mami Ikenoya Japan 5 237 1.1× 33 0.7× 22 0.5× 27 0.7× 36 0.9× 6 358
Carolyn Tallon United States 13 208 1.0× 53 1.1× 38 0.9× 61 1.5× 58 1.5× 17 363
E Corbin United States 7 496 2.3× 92 2.0× 67 1.6× 30 0.7× 44 1.1× 11 581
Sandra Fernaeus Sweden 10 280 1.3× 31 0.7× 44 1.0× 94 2.3× 15 0.4× 12 374

Countries citing papers authored by K. Warecka

Since Specialization
Citations

This map shows the geographic impact of K. Warecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Warecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Warecka more than expected).

Fields of papers citing papers by K. Warecka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Warecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Warecka. The network helps show where K. Warecka may publish in the future.

Co-authorship network of co-authors of K. Warecka

This figure shows the co-authorship network connecting the top 25 collaborators of K. Warecka. A scholar is included among the top collaborators of K. Warecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Warecka. K. Warecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Claus, D., Reinhard Eggers, A. Engelhardt, B. Neundörfer, & K. Warecka. (2009). Ethanol and polyneuropathy. Acta Neurologica Scandinavica. 72(3). 312–316. 7 indexed citations
2.
Schürmann, Martin, et al.. (1993). Auditory evoked potentials in multiple sclerosis: Alpha responses are reduced in amplitude, but theta responses are not altered. International Journal of Neuroscience. 73(3-4). 259–276. 6 indexed citations
3.
Warecka, K., et al.. (1993). Visual evoked potentials in multiple sclerosis: Frequency response shows reduced alpha amplitude. International Journal of Neuroscience. 73(3-4). 235–258. 8 indexed citations
4.
Claus, D., Reinhard Eggers, K. Warecka, & B. Neund�rfer. (1985). Thiamine deficiency and nervous system function disturbances. European Archives of Psychiatry and Clinical Neuroscience. 234(6). 390–394. 17 indexed citations
5.
Warecka, K., et al.. (1985). Zur sporadisch und familiär auftretenden multiplen Sklerose (MS). Fortschritte der Neurologie · Psychiatrie. 53(4). 134–137. 1 indexed citations
6.
Ghandour, M. Saïd, O.K. Langley, G. Gombos, G. Vincendon, & K. Warecka. (1982). Cellular localization of the brain specificα2-glycoprotein in rat cerebellum: An immunohistological study. Neuroscience. 7(1). 231–237. 4 indexed citations
7.
Rasmussen, Søren, et al.. (1980). Quantitation of glial fibrillary acidic protein in human brain tumours. British Journal of Cancer. 41(1). 113–116. 17 indexed citations
8.
Warecka, K., et al.. (1976). Primary malignant melanoma of the gallbladder. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 370(3). 233–238. 28 indexed citations
9.
Warecka, K.. (1975). Immunological differential diagnosis of human brain tumours. Journal of the Neurological Sciences. 26(4). 511–516. 12 indexed citations
10.
Brunngraber, Eric G., et al.. (1974). Electrophoretic analysis of human brain‐specific proteins obtained by affinity chromatography. Journal of Neurochemistry. 22(1). 181–182. 9 indexed citations
11.
Warecka, K.. (1972). Immunological Studies of Brain Specific Protein. Advances in experimental medicine and biology. 21–38. 2 indexed citations
12.
13.
Warecka, K.. (1970). Isolation of brain‐specific glycoprotein1. Journal of Neurochemistry. 17(6). 829–830. 16 indexed citations
14.
Warecka, K. & David W.M. Muller. (1969). The appearance of human “brain-specific” glycoprotein in ontogenesis. Journal of the Neurological Sciences. 8(2). 329–345. 20 indexed citations
15.
Warecka, K. & Heike Bauer. (1968). Untersuchungen �ber ein hirnspezifisches alpha2-glykoprotein in der fetalen und postnatalen Lebensperiode beim Menschen. Journal of Neurology. 194(1). 66–75. 13 indexed citations
16.
Warecka, K.. (1967). Immunochemical studies on a water-soluble-brain specific glycoprotein from human and rat brain. Life Sciences. 6(18). 1999–2002. 11 indexed citations
17.
Warecka, K. & Heike Bauer. (1967). STUDIES ON ‘BRAIN‐SPECIFIC’ PROTEINS IN AQUEOUS EXTRACTS OF BRAIN TISSUE. Journal of Neurochemistry. 14(7). 783–787. 49 indexed citations
18.
Warecka, K. & H. Bauer. (1966). [Studies on brain proteins. Immunochemical studies of the water soluble fractions].. PubMed. 189(1). 53–66. 8 indexed citations
19.
Warecka, K., et al.. (1966). Immunophoretic Evaluation of Blood Serum Proteins in Chickens. I. Changing Protein Patterns in Chickens According to Age.. Experimental Biology and Medicine. 122(3). 729–732. 8 indexed citations
20.
Miller, Henry, et al.. (1964). Multiple sclerosis in Poland and in northern England. Neurology. 14(9). 779–779. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Keith Del Villar Breakdown of academic impact, for papers by Perry J. Hartfield Breakdown of academic impact, for papers by Kenji Yamamoto Breakdown of academic impact, for papers by Tessa Grabinski Breakdown of academic impact, for papers by V. T. Solovyan Breakdown of academic impact, for papers by Jacqueline Tiong Breakdown of academic impact, for papers by Mami Ikenoya Breakdown of academic impact, for papers by Carolyn Tallon Breakdown of academic impact, for papers by E Corbin Breakdown of academic impact, for papers by Sandra Fernaeus
Rankless by CCL
2026